On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...
The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...
By Blake Brittain WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving ...
Generic and branded drug manufacturers may soon have long-awaited answers from the Supreme Court regarding skinny labeling practices. On January ...
The Alabama Supreme Court recently reaffirmed that patients are allowed to sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback